NEUROGEN CP NRGN (NASDAQd)

$ 0.26
10:52
Sponsored by
Click here!
Change: +0.01 (+4.00%)
Volume: 20,000

Avg. Volume: 95060
P/E Ratio: 0
EPS (Annual): -1.22
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 42,160
Institutional Shareholders: 52.45%
Last: 0.26
Change: +0.01 (+4.00%)
Prev. Close: 0.25
Open: 0.22
Day's Range: 0.22 - 0.28
52wk Range: 0.22 - 4.59
Market Value: 18,990
Beta: 1.54
12-month EPS Change: -27.97%
Total Return Last 12 Months: -94.66%
Total Return Last 3 Years: -125.43%
Total Return Last 5 Years: -96.18%
5-Year Revenue Growth Rate: -1.83%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -1.48%


Headlines on NRGN
Alert me Subscribe

Neurogen stops adipiplon trial due to side effects

(BRANFORD, Conn.)Biotechnology company Neurogen Corp. said Sunday it stopped a clinical trial of its insomnia candidate adipiplon because some patients experienced grogginess and memory loss. The s...READ MORE
Jul 14, 2008 5:22PM
Keywords: NRGN
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement